Miguel Lopez-Toledano, PhD
- 2Articles
- 25.4KReads1
- 2024–2025Active
- 10Collaborators
- 5Citations2
About
Miguel Lopez-Toledano, PhD, is affiliated with Clinical Development and Medical Affairs at Neurelis Inc in San Diego, California. His publications focus on bipolar disorder, schizophrenia and schizoaffective disorders, and complementary and alternative medicine. He has contributed to research on the pharmacokinetics of olanzapine formulations and alternative approaches for managing acute agitation in psychiatric conditions. His work has appeared in Psychiatrist.com between 2024 and 2025.
Publications
Alternative Treatment for Agitation in Schizophrenia and Bipolar Disorder
January 30, 2024
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.